Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds DYNE.
No tracked institution reports a position in DYNE as of their last filing.
No one on the platform has traded DYNE yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
@ZacksResearch Exon skippers like $DYNE DYNE-251 or Avidity/Novartis $RNA $NVS del-zeta, and drugs designed to improve muscle mass and retrograde signaling like $KROS KER-065 or $SRRK's apitegromab are complementary and not competing. Ultimately they should be tested in combination once they show efficacy as single therapies.
View on StockTwits ↗$DYNE Gallant Capital Partners Invests in Cybersecurity Firms DynTek and rSolutions to Support Growth and Innovation https://www.stocktitan.net/news/DYNE/gallant-capital-partners-invests-in-cybersecurity-firms-dyn-tek-and-nz9at2wmkp7n.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.